Text Registration
Copyright Title
IBM Merge Hemo 10.4 Adverse Drug Event Checking
Status
Published
on 26 May 2021
Year of Creation
2021
Copyright Claimant
International Business Machines Corporation
Registration Number
TX0008999161
on 26 May 2021Copyright Summary
The U.S. Copyright record (Registration Number: TX0008999161) dated 26 May 2021, pertains to an electronic file (eService) titled "IBM Merge Hemo 10.4 Adverse Drug Event Checking" created in 2021. The copyright holder is International Business Machines Corporation, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to International Business Machines Corporation.
Application Details
Registration Number
TX0008999161
Registration Date
5/26/2021
Year of Creation
2021
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
International Business Machines Corporation
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: International Business Machines Corporation
Local Copyright Note: C.O. correspondence
Statements
Application Title Statement: IBM Merge Hemo 10.4 Adverse Drug Event Checking
Author Statement: International Business Machines Corporation employer for hire Citizenship: United States Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.